ライフサイエンスコーパス: atrial flutter

1 DRA preferred terms ("atrial fibrillation," "atrial flutter").

2 ure (the latter was performed for persistent atrial flutter).

3 y right or left ventricular pacing, and (iv) atrial flutter.

4 brillation developed in 56% of patients with atrial flutter.

5 l ectopic tachycardia, and 3 of 9 (33%) with atrial flutter.

6 atrial myopathy seems to promote left septal atrial flutter.

7 e to first-line therapy for the treatment of atrial flutter.

8 e incidence and mechanisms of atypical right atrial flutter.

9 at 45 sites in 10 consecutive patients with atrial flutter.

10 he standard initial therapeutic approach for atrial flutter.

11 d to subsequently initiate isthmus-dependent atrial flutter.

12 e to subsequently initiate isthmus-dependent atrial flutter.

13 ht to characterize the posterior boundary of atrial flutter.

14 at 72 sites on complete maps of 24 atypical atrial flutter.

15 atrium during counterclockwise and clockwise atrial flutter.

16 prophylaxis against atrial fibrillation and atrial flutter.

17 DCCV for symptomatic atrial fibrillation or atrial flutter.

18 and contact electrograms was 0.85+/-0.17 in atrial flutter.

19 pacemaker and only 10 (4.1%) had documented atrial flutter.

20 trigger rather than a consequence of type I atrial flutter.

21 of slow conduction in the reentry circuit of atrial flutter.

22 re thought to be rare after cardioversion of atrial flutter.

23 relation with the duration of previous AF or atrial flutter.

24 lism in patients undergoing cardioversion of atrial flutter.

25 B) to the isthmus in 14 patients with type I atrial flutter.

26 atrial fibrillation and 14 (74%) of 19 with atrial flutter.

27 65 +/- 52 s-1, respectively (p < 0.001), in atrial flutter.

28 right atrium) to assess efficacy at inducing atrial flutter.

29 theter ablation similar to isthmus block for atrial flutter.

30 tinguished isthmus from nonisthmus dependent atrial flutter.

31 for the treatment of atrial fibrillation and atrial flutter.

32 sistent AF, 6% had paroxysmal AF, and 5% had atrial flutter.

33 nt circuits in the majority of patients with atrial flutter.

34 of the TI isthmus-dependent clockwise right atrial flutters.

35 disposing risks were labeled as having "lone atrial flutter."

36 Among those with atrial flutter 16% were attributable to heart failure an

37 recurrences in patients with any history of atrial flutter (16.7% vs. 60.9%, p = 0.009).

38 ersion was less pronounced in the group with atrial flutter (27 +/- 18 cm/s for atrial flutter vs. 15

39 patients with chronic AF and 13 with chronic atrial flutter (3 weeks to 3 years in duration) the rela

40 ial free wall activation direction as during atrial flutter; (4) another delay on the lateral right a

41 14 cm/s after cardioversion, p < 0.001) and atrial flutter (42 +/- 19 to 27 +/- 18 cm/s, respectivel

42 thmic drugs, 38% had AF, 17% had both AF and atrial flutter, 9% had persistent atrial flutter, and 3%

43 pping is an established approach to atypical atrial flutter ablation, postpacing intervals shorter th

44 ation, invasive electrophysiology testing or atrial flutter ablation.

45 or programmed electrical stimulation-induced atrial flutter acceleration in human subjects.

46 In five patients, 27 episodes of atrial flutter acceleration were induced by single extra

47 ical prediction rule for atrial fibrillation/atrial flutter (AF) after coronary artery bypass graftin

48 ved for treatment of atrial fibrillation and atrial flutter (AF).

49 nction before and after catheter ablation of atrial flutter (AFI).

50 We studied the safety and efficacy of atrial flutter (AFL) ablation using 8- or 10-mm electrod

51 of this study was to assess the incidence of atrial flutter (AFL) after pulmonary vein antrum isolati

52 Atrial flutter (AFL) and atrial fibrillation (AF) are as

53 Atrial flutter (AFL) and atrial fibrillation (AF) freque

54 participant in atrial arrhythmias, including atrial flutter (AFL) and atrial fibrillation (AF).

55 ngs action potential duration and terminates atrial flutter (AFL) and fibrillation (AF), but the mech

56 In patients with atrial flutter (AFL) and postoperative right atrial inci

57 nce of new-onset atrial fibrillation (AF) or atrial flutter (AFL) and their influence on clinical out

58 terclockwise isthmus-dependent (CCWID) right atrial flutter (AFL) and to attempt to correlate F-wave

59 ne the atrial remodeling caused by sustained atrial flutter (AFL) and/or atrial fibrillation (AF).

60 Atrial fibrillation (AF) and atrial flutter (AFL) are associated with both diabetes m

61 erms counterclockwise (CC) and clockwise (C) atrial flutter (Afl) are used to describe right atrial a

62 ization to lisinopril reduces incident AF or atrial flutter (AFL) compared with chlorthalidone in a l

63 g interval (PPI) upon entrainment of typical atrial flutter (AFL) from the cavotricuspid isthmus (CTI

64 of 28 (8%) of 372 consecutive patients with atrial flutter (AFL) had 36 episodes of sustained atypic

65 ought to characterize the clinical nature of atrial flutter (AFL) in a large cohort of infants.

66 n for those with atrial fibrillation (AF) or atrial flutter (AFL) receiving long-term treatmentwith c

67 The mechanisms of an atrial flutter (AFL) that is more rapid and at times mor

68 the prevalence and clinical significance of atrial flutter (AFL) that occurs during catheter ablatio

69 hanisms underlying the transition of typical atrial flutter (Afl) to fibrillation (AF) remain unclear

70 de in converting atrial fibrillation (AF) or atrial flutter (AFl) to sinus rhythm (SR) and maintainin

71 The purpose of this study was to separate atrial flutter (AFL) with atypical F waves from fibrilla

72 A, 59% had atrial fibrillation (AF), 14% had atrial flutter (AFL), and 27% had both AF and AFL.

73 Four patients had right atrium incisional atrial flutter (AFL), and 6 had LA incisional AFL, which

74 ir pattern during counterclockwise (CCW) CTI atrial flutter (AFL), except for decreased amplitude of

75 ndergoing radiofrequency ablation of typical atrial flutter (AFL).

76 nce and quality of life in coexistent AF and atrial flutter (AFL).

77 , often coexists with the related arrhythmia atrial flutter (AFL).

78 ncy ablation of atrial fibrillation (AF) and atrial flutter (AFL).

79 ionship between atrial fibrillation (AF) and atrial flutter (AFL).

80 In patients presenting with atrial flutter after LA ablation, entrainment mapping sh

81 The high recurrence rate of atrial flutter after presumed successful ablation may be

82 t catheter ablation for recurrent AF or left atrial flutter after the hybrid procedure.

83 endage stunning also occurs in patients with atrial flutter, although to a lesser degree than in thos

84 of counterclockwise and/or clockwise typical atrial flutter, an additional atypical atrial flutter wa

85 of ibutilide converted 54% of patients with atrial flutter and 39% of patients with atrial fibrillat

86 case of a 62-year old female with paroxysmal atrial flutter and atrial fibrillation, whose cardiac co

87 15 patients with AF and 5 patients each with atrial flutter and atrioventricular nodal reentrant tach

88 gnificantly different from that required for atrial flutter and AVNRT.

89 s contrast are not uncommon in patients with atrial flutter and cardioversion may be associated with

90 Sixteen patients had inducible AF or atrial flutter and could be tested after dual-site atria

91 ation between suppression of inducible AF or atrial flutter and demographic or clinical patient chara

92 LLR is a subtype of right atrial flutter and depends on conduction through the TA-

93 100302, and the partial agonist cisapride on atrial flutter and fibrillation induced in swine were st

94 n placebo in the pharmacologic conversion of atrial flutter and fibrillation to sinus rhythm.

95 idence of atrial arrhythmias, with inducible atrial flutter and fibrillation.

96 Previous studies using ICE during mapping of atrial flutter and inappropriate sinus tachycardia have

97 date discusses the classification schemes of atrial flutter and macroreentrant atrial tachycardias, r

98 ces between patients with cardioversion from atrial flutter and those with cardioversion from AF.

99 mboembolic events in the presence of chronic atrial flutter and to determine the impact of anticoagul

100 nd highlights recent ablation approaches for atrial flutters and macroreentrant atrial tachycardias.

101 oth AF and atrial flutter, 9% had persistent atrial flutter, and 3% had paroxysmal AF on antiarrhythm

102 in patients who have atrial fibrillation or atrial flutter, and data point to an important role for

103 ing sinus rhythm, demonstrate reentry during atrial flutter, and describe right atrial activation dur

104 ed with greater experience using Sotalol for atrial flutter, and digoxin and amiodarone for 1: 1 reci

105 from 17 simulations of atrial fibrillation, atrial flutter, and focal atrial tachycardia.

106 quency (RF) ablation of atrial fibrillation, atrial flutter, and nonidiopathic ventricular tachycardi

107 The rate of readmission for recurrent AF, atrial flutter, and/or repeat ablation was 21.7% by 1 ye

108 Patients with chronic atrial flutter are at an increased risk of thromboemboli

109 These data suggest that patients with atrial flutter are at risk for thromboembolic events aft

110 At highest risk of developing atrial flutter are men, the elderly and individuals with

111 de catheters was characteristic of clockwise atrial flutter around the TA.

112 similar to that of counterclockwise typical atrial flutter around the tricuspid annulus (TA).

113 gency department with atrial fibrillation or atrial flutter as a primary or secondary diagnosis.

114 ECG with a rhythm of atrial fibrillation or atrial flutter as positive for atrial fibrillation.

115 fractions (p = 0.0001), and more concomitant atrial flutter at baseline (p < 0.0001).

116 consecutive patients with ablation of type I atrial flutter, atrial fibrillation was documented in 28

117 We identified D1275N in a patient with atrial flutter, atrial standstill, conduction disease, a

118 nced the first recurrence of symptomatic AF, atrial flutter, atrial tachycardia (HR, 0.56 [95% CI, 0.

119 bsequent AT (comprising atrial fibrillation, atrial flutter, atrial tachycardia, and supraventricular

120 luding bradyarrhythmias, atrial fibrillation/atrial flutter, atrial tachycardia, atrioventricular nod

121 l AV-conduction block (2 cases), (post)ictal atrial flutter/atrial fibrillation (14 cases) and postic

122 ordant alternans, underlies the induction of atrial flutter/atrial fibrillation by atrial ectopic foc

123 each foci location, a vulnerable window for atrial flutter/atrial fibrillation induction was identif

124 The mechanisms underlying paroxysmal atrial flutter/atrial fibrillation initiation by ectopic

125 Primary effectiveness was freedom from AF/atrial flutter/atrial tachycardia absent new/increased d

126 at procedures and long-term recurrence of AF/atrial flutter/atrial tachycardia are significantly lowe

127 s, 12-month freedom from atrial fibrillation/atrial flutter/atrial tachycardia recurrence was 72.5%.

128 At 1-year follow-up, freedom from AF/atrial flutter/atrial tachycardia recurrence was signifi

129 es (47 patients with AF and 16 patients with atrial flutter/atrial tachycardia) after the initial pro

130 malous bundles, ventricular premature beats, atrial flutter, atrioventricular nodal reentry, and atri

131 ing order of frequency, atrial fibrillation, atrial flutter, atrioventricular nodal reentry, Wolff-Pa

132 investigated the mechanism of initiation of atrial flutter, before ablation, to determine the site o

133 ime of conversion and included appearance of atrial flutter, bradycardia, pauses and junctional rhyth

134 rrhythmia is frequently referred to as "left atrial flutter," but the mechanism and best ablation str

135 Atrial flutter can arise in the right atrial free wall.

136 Although atrial flutter can now be cured, there are no reports on

137 Catheter cryoablation of common atrial flutter causes much less patient discomfort than

138 nd demonstrating conduction block within the atrial flutter circuit after ablation.

139 stics of a novel macroreentrant form of left atrial flutter circuit.

140 s also had a lower adjusted risk of incident atrial flutter compared with whites, the risk of flutter

141 terms adverse effects, atrial fibrillation, atrial flutter, congestive heart failure, electrical sto

142 This form of atypical atrial flutter could account for spontaneous or inducibl

143 duced after lesion set completion, sustained atrial flutter could be induced in 25% of the hearts.

144 right atrium (283+/-52 ms); and (5) typical atrial flutter (cycle length, 245+/-38 ms).

145 hypothesis that the direction of rotation of atrial flutter depends on the pacing site from which it

146 During follow-up, left atrial flutter developed in 19% of patients and was stil

147 dents was used to ascertain all new cases of atrial flutter diagnosed from July 1, 1991 to June 30, 1

148 Post-ablation atrial flutter did not differ between groups: 5.1% in PV

149 "Atrial fibrillation" was defined as AF or atrial flutter documented by electrocardiogram or prior

150 illation (166+/-236 seconds) converting into atrial flutter during electrophysiological evaluation we

151 rience cavotricuspid isthmus (CTI)-dependent atrial flutter during follow-up.

152 (3) In 10 cases of atrial tachycardia/atrial flutter, ECM accurately identified the chamber of

153 rhythm, A-V dissociation, sinus bradycardia, atrial flutter, escape-capture bigeminy, and atrial prem

154 Patients with atrial flutter exhibited greater left atrial appendage f

155 Onset of atrial flutter/fibrillation (AFF) in patients who have u

156 c target in the control of AVN conduction in atrial flutter/fibrillation, one of the most common arrh

157 s tricuspid regurgitation was for those with atrial flutter/fibrillation.

158 erclockwise (CCW) and clockwise (CW) typical atrial flutter (Fl) in patients with and without structu

159 mained AF-free and 74% AF/atrial tachycardia/atrial flutter-free during follow-up on or off AADs.

160 -free and 66% remained AF/atrial tachycardia/atrial flutter-free on or off AADs (antiarrhythmic drugs

161 Atrial flutter frequently occurs in patients with AF.

162 logy laboratory for cardioversion of chronic atrial flutter from 1986 to 1996.

163 350 ms, APD90 was shorter in both the AF and atrial flutter groups than in the control group (p < 0.0

164 Patients with atrial flutter had a greater response to dofetilide (54%

165 er adjustment for age and sex, patients with atrial flutter had a higher incidence of thromboembolic

166 Lone atrial flutter has a stroke risk at least as high as lon

167 Atrial flutter has been mapped using sequential techniqu

168 The electrophysiologic substrate of typical atrial flutter has not been well characterized.

169 Atrial flutter has not recurred in any patient (follow-u

170 Previous studies of atrial flutter have found linear block at the crista ter

171 In the patients with atrial flutter, ibutilide had a significantly higher suc

172 ition to terminating atrial fibrillation and atrial flutter, ibutilide significantly reduces human at

173 ant tachycardia (IART) and isthmus-dependent atrial flutter (IDAF) in patients presenting with suprav

174 this study was to separate isthmus-dependent atrial flutter (IDAFL) from non-isthmus-dependent atrial

175 id isthmus-dependent macroreentrant atypical atrial flutter in 19 consecutive patients.

176 of 100 randomized patients (for AF in 30 and atrial flutter in 4).

177 RS-100302 terminated atrial flutter in 6 of 8 animals and atrial fibrillation

178 ation in 26 percent of patients and atypical atrial flutter in 6 percent.

179 The only complication was left atrial flutter in a patient who underwent LACA.

180 ed and prevented the reinduction of atypical atrial flutter in each patient.

181 characterizing the various forms of atypical atrial flutter in humans are limited.

182 whether chronic atrial fibrillation (AF) and atrial flutter in patients lead to electrical remodeling

183 Atrial flutter in the absence of other arrhythmias has a

184 More patients had atrial fibrillation or atrial flutter in the albiglutide group (35 [1.4%] of 25

185 to determine the incidence and predictors of atrial flutter in the general population.

186 ts with at least two episodes of symptomatic atrial flutter in the last four months were randomized t

187 population, we estimate 200,000 new cases of atrial flutter in this country annually.

188 vely in patients with atrial fibrillation or atrial flutter, in patients undergoing cardioversion of

189 The risk of developing atrial flutter increased 3.5 times (p < 0.001) in subjec

190 Data from experimental models of atrial flutter indicate that macro-reentrant circuits ma

191 drome (in three [18%] patients); and sepsis, atrial flutter, indirect hyperbilirubinaemia, cerebral h

192 acing to prevent atrial fibrillation (AF) or atrial flutter induced by single-site atrial pacing and

193 Fifty episodes of atrial flutter induced in 11 animals were evaluated.

194 d atrial stimulation was performed for AF or atrial flutter induction.

195 Successful ablation of atrial flutter involves (1) mapping the atrial flutter t

196 Atrial flutter is a macroreentrant tachyarrhythmia most

197 ng atrial fibrillation after presenting with atrial flutter is also reported.

198 Atrial flutter is characterized by a macroreentrant atri

199 Typical atrial flutter is defined on an electrocardiogram by the

200 re-entrant circuit to determine whether the atrial flutter is isthmus-dependent, non-isthmus-depende

201 The natural history of atrial flutter is not well defined.

202 anatomic and/or functional barriers, typical atrial flutter is sustained by a single reentrant circui

203 Although overdrive pacing for treating atrial flutter is well established, the efficacy of devi

204 ical studies with entrainment mapping of the atrial flutter isthmus for determining postpacing interv

205 te but have not systematically evaluated the atrial flutter isthmus in such patients.

206 We sought to determine the role of the atrial flutter isthmus in supporting IART in a group of

207 The fact that the atrial flutter isthmus is vulnerable to ablation suggest

208 ter repair of a congenital heart defect, the atrial flutter isthmus should be evaluated.

209 The atrial flutter isthmus was part of the circuit in 15 of

210 In most of our postoperative patients, the atrial flutter isthmus was part of the reentrant circuit

211 ) IARTs and in 14 of 15 (93.3%) cases at the atrial flutter isthmus.

212 ptomatic recurrence of AF/atrial tachycardia/atrial flutter lasting >30 seconds, determined 3 months

213 These data confirm that both AF and atrial flutter lead to electrical remodeling in the huma

214 AF and atrial flutter lead to marked, quantitatively similar de

215 dependent, or atypical; (2) interrupting the atrial flutter macroreentrant circuit with an ablation c

216 Atrial arrhythmias are frequent, and atrial flutter may be a marker for sudden death.

217 s intra-atrial block, sinus bradycardia, and atrial flutter, may be attributed to changes in atrial s

218 Seven patients had classic atrial flutter morphology on surface electrocardiogram (

219 /- 16 years) with symptomatic AF (n = 10) or atrial flutter (n = 10) were studied.

220 Sixty-three patients with atrial flutter (n = 19) or atrial fibrillation (n = 44)

221 (56%), who had either induced AF (n = 5) or atrial flutter (n = 4).

222 The cause was atrial fibrillation (n=13), atrial flutter (n=4), atrial tachycardia (n=3), idiopath

223 ias included cavotricuspid isthmus-dependent atrial flutter (n=7), non-isthmus-dependent right atrial

224 Atrial flutter never degenerated into fibrillation, even

225 l flutter (IDAFL) from non-isthmus-dependent atrial flutter (NIDAFL) from the electrocardiogram (ECG)

226 r could account for spontaneous or inducible atrial flutter observed in patients referred for ablatio

227 as seen in 7 patients, and isthmus-dependent atrial flutter occurred in 14 patients.

228 Left atrial flutter occurred in 17% and 27% of patients in ea

229 l consecutive patients presenting with AF or atrial flutter on DOAC were included.

230 ce, atrial burst pacing consistently induced atrial flutter or AF in Casq2-/- mice and in isolated Ca

231 In patients with cardioversion from atrial flutter or AF, the steady state cycle length-APD9

232 boembolic events occurred during a rhythm of atrial flutter or after cardioversion to sinus rhythm.

233 rrence of atrial fibrillation, occurrence of atrial flutter or atrial tachycardia, use of antiarrhyth

234 ients with a history of atrial fibrillation, atrial flutter or both were randomly assigned to receive

235 ients with a history of atrial fibrillation, atrial flutter or both.

236 rences in patients with atrial fibrillation, atrial flutter or both.

237 ven patients (age range 22 to 92 years) with atrial flutter or fibrillation of 3 h to 90 days' (mean

238 17 anesthetized, open-chest, juvenile pigs, atrial flutter or fibrillation was induced by rapid righ

239 s rhythm and 15 patients after conversion of atrial flutter or fibrillation were evaluated.

240 ong atrial action potentials and may prevent atrial flutter or fibrillation without affecting ventric

241 Patients (n = 44) with bundle branch blocks, atrial flutter or fibrillation, pacemaker rhythm, recent

242 ied suddenly, and 29 had new-onset sustained atrial flutter or fibrillation.

243 es and may have relevance for maintenance of atrial flutter or fibrillation.

244 hythmias, and 865 (36%) having postoperative atrial flutter or fibrillation.

245 procainamide for conversion of recent-onset atrial flutter or fibrillation.

246 RM ablation terminated AF to sinus rhythm or atrial flutter or tachycardia in 59% (PAF), 37% (PeAF),

247 point was freedom from atrial fibrillation, atrial flutter, or atrial tachycardia at 12 months.

248 nth recurrence, defined as an episode of AF, atrial flutter, or atrial tachycardia lasting >30 second

249 elihood of freedom from atrial fibrillation, atrial flutter, or atrial tachycardia while not receivin

250 atrial tachyarrhythmia (atrial fibrillation, atrial flutter, or atrial tachycardia) between 91 and 36

251 or asymptomatic atrial tachyarrhythmia (AF, atrial flutter, or atrial tachycardia) between days 91 a

252 30 seconds (symptomatic or asymptomatic AF, atrial flutter, or atrial tachycardia), detected by eith

253 Recurrence was defined as >30 seconds of AF, atrial flutter, or atrial tachycardia.

254 trial fibrillation versus 4 (21%) of 19 with atrial flutter (p < 0.05).

255 w-onset postoperative atrial fibrillation or atrial flutter (pAF) that could be related to rDA admini

256 rdings only for atrial fibrillation and some atrial flutter propagations patterns, and HDF filtering

257 ed the outcome at follow-up of patients with atrial flutter randomly assigned to drug therapy or RF a

258 istory of symptomatic atrial fibrillation or atrial flutter received placebo or azimilide (35 to 125

259 thmus (CTI) conduction block reduces typical atrial flutter recurrences after ablation.

260 establishment of a stable substrate for the atrial flutter reentrant circuit.

261 elocity, and medications in patients with AF/atrial flutter referred for DC cardioversion.

262 f therapy, end points included recurrence of atrial flutter, rehospitalization and quality of life.

263 atrial fibrillation after ablation of type I atrial flutter remains an important clinical problem.

264 In a selected group of patients with atrial flutter, RF ablation could be considered a first-

265 Episodes of a right atrial flutter rhythm that was different from typical AF

266 esponse was observed in most cases of type I atrial flutter, signifying a fully excitable gap in all

267 Conclusions In atypical atrial flutter, sites with dPPI <0 are markers of limite

268 the first population-based investigation of atrial flutter, suggests this curable condition is much

269 as exercise-induced atrial fibrillation (AF)/atrial flutter, supraventricular tachycardia (SVT), or A

270 onversion rates at all doses were higher for atrial flutter than for atrial fibrillation.

271 years of age, she experienced an episode of atrial flutter that was treated with electrical cardiove

272 During mapping of VT and atrial flutter, the N + 1 difference correlated well wit

273 iant patients who present for ablation in AF/atrial flutter, the procedures could be performed withou

274 Except for atypical atrial flutter, there were no complications attributable

275 th cardioversion; postoperative AF excluding atrial flutter; time to first postoperative AF; number o

276 n of atrial flutter involves (1) mapping the atrial flutter to define the conduction zones within the

277 nts to convert either atrial fibrillation or atrial flutter to sinus rhythm.

278 e estimated lifetime risks for AF (including atrial flutter) to age 95 years, with death free of AF a

279 y Cause in Patients With Atrial Fibrillation/Atrial Flutter) trial, which demonstrated a significant

280 deviation, 68 years +/- 10) with symptomatic atrial flutter underwent isthmus ablation.

281 pothesis in patients undergoing ablation for atrial flutter using a novel ECG algorithm to detect sub

282 ocardial activation during the initiation of atrial flutter via fibrillation and the rarity of degene

283 roup with atrial flutter (27 +/- 18 cm/s for atrial flutter vs. 15 +/- 14 cm/s for atrial fibrillatio

284 Atrial flutter was 2.5 times more common in men (p < 0.0

285 Atrial flutter was induced in 52 (6.2%) of 838 attempted

286 pical atrial flutter, an additional atypical atrial flutter was mapped to the right atrial free wall.

287 However, atrial flutter was recorded after the completion of the

288 After era correction, the incidence of atrial flutter was similar and strongly associated with

289 A total of 181 new cases of atrial flutter were diagnosed for an overall incidence o

290 18,201 patients with AF or atrial flutter were randomly assigned to receive apixaba

291 ogy on surface ECG consistent with clockwise atrial flutter were studied.

292 Twelve patients with typical atrial flutter were studied.

293 The most common arrhythmia was atrial flutter, which occurred in 9% of this cohort.

294 n should be considered for all patients with atrial flutter who are older than 65 years of age.

295 gh-sensitivity CRP in 67 patients with AF or atrial flutter who underwent successful electrical CV.

296 Inpatients or observed patients with AF or atrial flutter will be enrolled.

297 Right atrial flutter with positive flutter waves in the inferi

298 compared the stroke rate in 59 patients with atrial flutter with rates in a sample in which age- and

299 Most right atrial flutters with positive flutter wave on surface EC

300 hs, 77% of patients were free from AF and/or atrial flutter without antiarrhythmic drug therapy.